Drawing for RECATALF

USPTO serial 79252108

RECATALF

Reviewed by CopyMark Law Group

Reg. 5816248Status 709
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RECATALF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparation for the treatment of congenital and acquired antithrombin deficiency; pharmaceutical preparation comprising an isolated, recombinant antithrombin III; pharmaceutical preparation for inhibiting blood coagulationSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 13, 2026C71TCANCELLED SECTION 71—
May 18, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Nov 15, 2019GPNXNOTIFICATION PROCESSED BY IB—
Oct 8, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 18, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 18, 2019FIMPFINAL DISPOSITION PROCESSED—
Aug 29, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2019NPUBNOTICE OF PUBLICATION—
Mar 30, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 2019DOCKASSIGNED TO EXAMINER—
Feb 26, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 19, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 14, 2019SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance